Source: Health Products Regulatory Authority (IE) Revision Year: 2019 Publisher: UCB (Pharma) Ireland Limited, United Drug House, Magna Drive, Magna Business Park, Citywest Road, Dublin 24, Ireland
Muntel 5 mg Film-coated Tablets.
| Pharmaceutical Form |
|---|
|
Film-coated tablet. White to off-white, oval, film-coated tablet with a Y logo on one side. |
Each film-coated tablet contains 5 mg levocetirizine dihydrochloride.
Excipient with known effect: 63.50 mg lactose monohydrate/tablet.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Levocetirizine |
Levocetirizine, the ® enantiomer of cetirizine, is a potent and selective antagonist of peripheral H1-receptors. Pharmacodynamic studies in healthy volunteers demonstrate that, at half the dose, levocetirizine has comparable activity to cetirizine, both in the skin and in the nose. |
| List of Excipients |
|---|
|
Core: Microcrystalline cellulose Coating: Opadry Y-1-7000 consisting of: Hypromellose (E464) |
Aluminium – OPA/aluminium/PVCblister.
Pack sizes of 1, 2, 4, 5, 7, 10, 2 × 10, 10 × 10, 14, 15, 20, 21, 28, 30 40, 50, 60, 70, 90, 100.
Not all pack sizes may be marketed.
UCB (Pharma) Ireland Limited, United Drug House, Magna Drive, Magna Business Park, Citywest Road, Dublin 24, Ireland
PA0891/006/001
Date of first authorisation: 2nd July 2004
Date of last renewal: 3rd January 2012
| Drug | Countries | |
|---|---|---|
| MUNTEL | Spain, Ireland |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
